Steven Cohen’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.3M Buy
753,741
+220,188
+41% +$731K ﹤0.01% 2327
2026
Q2
$1.97M Buy
+533,553
New +$1.77M ﹤0.01% 2399
2026
Q1
– Sell
-551,030
Closed -$1.91M – 4335
2025
Q4
$1.91M Buy
+551,030
New +$2.45M ﹤0.01% 2502
2025
Q1
– Sell
-68,528
Closed -$200K – 2439
2024
Q4
$200K Buy
+68,528
New +$241K ﹤0.01% 1882

Other funds holding PRME

Steven Cohen's PRME Position: Q3 2026 in Review

Steven Cohen increased its Prime Medicine (PRME) stake by 41% in Q3 2026, buying an estimated $731K and bringing the position to 753,741 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

Steven Cohen first reported a position in PRME in Q4 2024 and has held it in 4 quarters since. 186 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Steven Cohen held 753,741 shares of Prime Medicine worth $2.3M as of Q3 2026.
  • Steven Cohen bought 220,188 Prime Medicine shares in Q3 2026, an estimated $731K.
  • Prime Medicine made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2327 holding.
  • Steven Cohen first reported a position in Prime Medicine in Q4 2024 and has held it in 4 quarters since.
  • 186 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.